Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging

Table 3 Bivariate analysis of liver transplant predictors

Variable	Liver transplant		P value
	No	Yes
Gender (Male), n (%)	70 (42.9)	93 (57.1)	0.451
Age (yr), (mean, ± SD, range)	58.1 ± 8.7 (27-77)	57.9 ± 7.8 (32-73)	0.8861
Child-Pugh score, n (%)			0.644
A (5-6)	43 (44.8)	53 (55.2)
B (7-9)	33 (40.7)	48 (59.3)
C (10-15)	7 (53.8)	6 (46.2)
MELD, mean ± SD, range	11 (6-28)	12 (7-23)	0.0552
AFP (ng/dL), (mean, ± SD, range)	12.75 (0.6-22,411)	8.8 (1.1-8,216)	0.3352
Coagulopathy, n (%)			0.001
No	60 (55.0)	49 (45.0)
Yes	27 (30.7)	61 (69.3)
Trombocytopenia, n (%)			0.002
No	42 (58.3)	30 (41.7)
Yes	45 (36.0)	80 (64.0)
Group, n (%)			< 0.001
Downstaging	41 (66.1)	21 (33.9)
Bridging	46 (34.1)	89 (65.9)
Vascular lake phenomenon, n (%)			0.776
No	71 (44.7)	88 (55.3)
Yes	16 (42.1)	22 (57.9)
Total	87 (44.2)	110 (55.8)

Chi-squared test.

¹Student’s t test;

²Mann-Whitney test. AFP: Alpha-fetoprotein; HCC: Hepatocellular carcinoma; MELD: Model for End-Stage Liver Disease.